Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Trypanosomiasis, African

• Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients
• Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects
• ADME Study of Acoziborole in Healthy Subjects
• Efficacy and Safety of Fexinidazole in Patients With Human African Trypanosomiasis (HAT) Due to Trypanosoma Brucei Rhodesiense
• Prospective Study on Efficacy and Safety of Acoziborole (SCYX-7158) in Patients Infected by Human African Trypanosomiasis Due to T.b. Gambiense
• Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
• Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation
• Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal Study
• Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study
• Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2
• Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
• Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food
• Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole
• Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
• Trial of DB289 for the Treatment of Stage I African Trypanosomiasis
• A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis
• Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda
• Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis
• Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis